Iron Chelation Therapy Needed for Serum Ferritin Overloaded Patients of Beta Thalassemia Major

نویسندگان

چکیده

The main objective of the current study is to evaluate level and overload serum ferritin in multi-transfused beta Thalassemia major patients. There an earnest need defend chelation treatment make mindfulness about results patients major. This a Cross sectional analytical performed Fatimid foundation Hayatabad, Peshawar, Khyber Pakhtunkhwa province Pakistan. Those who has thalassemia are included this study. In there total 108 which 54 males females. highest mean category male was age 12 years were finds 8160.5 ng/mL. Among female 17 13,349.5 majority patient’s revealed much high levels ferritin. These reveal insufficient chelation. Appropriate iron load can improve quality life these low education, Poverty problems, health care facility obstacle effective management

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Combined chelation therapy with deferiprone and desferrioxamine in iron overloaded beta-thalassemia patients.

Dear Editor-in-Chief, We shortly report our results of combined iron chelation therapy with deferiprone (DFP) and desferrioxamine (DFX) versus chelation therapy with DFP alone, in iron overloaded β-thalassemia patients. Desferrioxamine has been a life saving iron chelator for thousands of patients in the last 40 years. However, less than 10% of the patients requiring iron chelation therapy worl...

متن کامل

Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major

There are few papers on the combination therapy of deferiprone (DFP) and deferasirox (DFX) in iron-overloaded patients with transfusion-dependent β-thalassemia major (β-TM). A total of 6 patients with β-TM (5 males and 1 female) with a mean age of 23.8±5.8 years (ranging from 17 to 31) used this treatment regimen. The mean doses of DFP and DFX were 53.9±22.2 and 29.3±6.8 mg/kg/day, respectively...

متن کامل

Efficacy of Chicory in Decreasing Serum Ferritin and Liver Enzymes in Major Beta Thalassemia Patients

Abstract Objective Thalassemia major is a severe transfusion-dependent anemia that needs iron chalation therapy to remove iron overload. The objectives of the present study were to assess the iron overload liver response to inulin of chicory supplementation by evaluating the serum ferritin and liver enzymes. Methods Among 70 beta thalassemia patients, 50 were selected for chelating therapy ...

متن کامل

Role of Iron Chelation Therapy in Thalassemia Major.

iron chelating therapy is the only method available for preventing early death caused mainly by myocardial and hepatic iron toxicity. Although desferrioxamine (DFO) has been available for treating transfusional iron overload from the early 1960s, the era of modern and effective iron chelating therapy started only 20 years ago with the introduction of subcutaneous DFO infusions by portable pumps...

متن کامل

Effective iron chelation practice for patients with β-thalassemia major.

Chronic blood transfusion is the only treatment for severe anemia in patients with β-thalassemia major. However, red blood cell transfusions lead to iron overload and subsequent organ damage because of the toxic effects of iron. The heart is particularly vulnerable to iron toxicity, and heart failure is the leading cause of death among these patients. Iron chelation therapy prevents or reverses...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Thalassemia Reports

سال: 2021

ISSN: ['2039-4357', '2039-4365']

DOI: https://doi.org/10.4081/thal.2021.9779